Innovative approaches and new thinking are needed to turn the tide on noncommunicable diseases (NCDs), including cancer.  

Liver cancer claims almost a million lives each year. Chronic viral hepatitis is its leading cause. As recognised in the political declaration of the fourth UN High-Level Meeting on NCDs and Mental Health (HLM4), diagnosis and treatment for hepatitis B and C, as well as vaccination for hepatitis B, can prevent new cases, increase early diagnosis and improve survival rates.  

This unique interactive session brings together stakeholders from across the political and global health landscape to explore how to accelerate country-level action to scale up person-centred liver cancer prevention and NCD control through hepatitis testing, treatment and vaccination.

Chaired by Rachel Halford, President of the World Hepatitis Alliance, speakers include:

•  Danjuma Adda, Executive Director, CFID Taraba and Chagro-Care Trust
• Anamaria Bejar, Director – Public Policy Engagement, Gavi, the Vaccine Alliance
• Cary James, Chief Executive, World Hepatitis Alliance
• Jessica Hicks, Senior Director, World Hepatitis Alliance
• Eliana Monteforte, Director of International Advocacy and Engagement, Global Health Council and Advisory Group Member of the Civil Society Engagement Mechanism (CSEM) for UHC2030
• Dr Zainab Shinkafi-Bagudu, President-elect, UICC
• Lujing Wang, MD, MPH, Managing Partner, Acsel Health

Speakers will discuss how the ‘Patient Charter to Improve Care for Hepatocellular Carcinoma’ and the World Hepatitis Alliance’s recent white paper, ‘Beating cancer through hepatitis elimination – working together to reduce NCDs’ can drive change. The NCD, cancer, hepatitis and universal health coverage (UHC) communities must come together to transform the response and save lives.